Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24980149)

1.

A novel miR-219-SMC4-JAK2/Stat3 regulatory pathway in human hepatocellular carcinoma.

Zhou B, Chen H, Wei D, Kuang Y, Zhao X, Li G, Xie J, Chen P.

J Exp Clin Cancer Res. 2014 Jun 30;33:55. doi: 10.1186/1756-9966-33-55.

2.

Overexpression of the structural maintenance of chromosome 4 protein is associated with tumor de-differentiation, advanced stage and vascular invasion of primary liver cancer.

Zhou B, Yuan T, Liu M, Liu H, Xie J, Shen Y, Chen P.

Oncol Rep. 2012 Oct;28(4):1263-8. doi: 10.3892/or.2012.1929. Epub 2012 Jul 24.

PMID:
22842912
3.

Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo.

Mohan CD, Bharathkumar H, Bulusu KC, Pandey V, Rangappa S, Fuchs JE, Shanmugam MK, Dai X, Li F, Deivasigamani A, Hui KM, Kumar AP, Lobie PE, Bender A, Basappa, Sethi G, Rangappa KS.

J Biol Chem. 2014 Dec 5;289(49):34296-307. doi: 10.1074/jbc.M114.601104. Epub 2014 Oct 15.

PMID:
25320076
4.

Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.

Buurman R, Gürlevik E, Schäffer V, Eilers M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F, Skawran B.

Gastroenterology. 2012 Sep;143(3):811-20.e1-15. doi: 10.1053/j.gastro.2012.05.033. Epub 2012 May 26.

PMID:
22641068
5.

Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.

Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G, Beckebaum S.

Mol Cancer. 2010 Aug 27;9:227. doi: 10.1186/1476-4598-9-227.

6.

IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma.

Gu FM, Li QL, Gao Q, Jiang JH, Zhu K, Huang XY, Pan JF, Yan J, Hu JH, Wang Z, Dai Z, Fan J, Zhou J.

Mol Cancer. 2011 Dec 15;10:150. doi: 10.1186/1476-4598-10-150.

7.

MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.

Huang XP, Hou J, Shen XY, Huang CY, Zhang XH, Xie YA, Luo XL.

FEBS J. 2015 Feb;282(3):579-94. doi: 10.1111/febs.13167. Epub 2014 Dec 27.

PMID:
25475121
8.

Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3.

Subramaniam A, Shanmugam MK, Ong TH, Li F, Perumal E, Chen L, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Hui KM, Sethi G.

Br J Pharmacol. 2013 Oct;170(4):807-21. doi: 10.1111/bph.12302.

9.

Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway.

Lv J, Ma L, Chen XL, Huang XH, Wang Q.

J Huazhong Univ Sci Technolog Med Sci. 2014 Jun;34(3):363-9. doi: 10.1007/s11596-014-1284-2. Epub 2014 Jun 18.

PMID:
24939300
10.

MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.

Xu L, Beckebaum S, Iacob S, Wu G, Kaiser GM, Radtke A, Liu C, Kabar I, Schmidt HH, Zhang X, Lu M, Cicinnati VR.

J Hepatol. 2014 Mar;60(3):590-8. doi: 10.1016/j.jhep.2013.10.028. Epub 2013 Nov 6.

PMID:
24211739
11.

Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.

Alpini G, Glaser SS, Zhang JP, Francis H, Han Y, Gong J, Stokes A, Francis T, Hughart N, Hubble L, Zhuang SM, Meng F.

J Hepatol. 2011 Dec;55(6):1339-45. doi: 10.1016/j.jhep.2011.04.015. Epub 2011 May 19.

12.

Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.

Hung TM, Ho CM, Liu YC, Lee JL, Liao YR, Wu YM, Ho MC, Chen CH, Lai HS, Lee PH.

PLoS One. 2014 Feb 20;9(2):e89446. doi: 10.1371/journal.pone.0089446. eCollection 2014.

13.

MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.

Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT.

Carcinogenesis. 2012 May;33(5):1113-20. doi: 10.1093/carcin/bgs113. Epub 2012 Feb 23.

14.

Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway.

Fu XT, Dai Z, Song K, Zhang ZJ, Zhou ZJ, Zhou SL, Zhao YM, Xiao YS, Sun QM, Ding ZB, Fan J.

Int J Oncol. 2015 Feb;46(2):587-96. doi: 10.3892/ijo.2014.2761. Epub 2014 Nov 18.

PMID:
25405790
15.

Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.

Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q, Cao P.

Cancer Lett. 2013 Jan 28;328(2):243-51. doi: 10.1016/j.canlet.2012.09.019. Epub 2012 Sep 29.

PMID:
23032719
16.

Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.

Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu H, Lian J, Chen L, Han J.

J Gastroenterol Hepatol. 2011 Nov;26(11):1630-7. doi: 10.1111/j.1440-1746.2011.06758.x.

PMID:
21557766
17.

MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.

Lu Y, Yue X, Cui Y, Zhang J, Wang K.

Biochem Biophys Res Commun. 2013 Nov 29;441(4):873-9. doi: 10.1016/j.bbrc.2013.10.157. Epub 2013 Nov 6.

PMID:
24211205
18.

Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism.

Cui ZH, Shen SQ, Chen ZB, Hu C.

World J Gastroenterol. 2014 May 14;20(18):5493-504. doi: 10.3748/wjg.v20.i18.5493.

19.

MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.

Xia H, Ooi LL, Hui KM.

PLoS One. 2012;7(9):e44206. doi: 10.1371/journal.pone.0044206. Epub 2012 Sep 4. Erratum in: PLoS One. 2012;7(9). doi:10.1371/annotation/1be2a62e-45a1-4c13-9a8d-f265005a21e0.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk